Patents by Inventor Thomas Edgington

Thomas Edgington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides That Bind To Atherosclerotic Lesions
    Publication number: 20070264194
    Abstract: The present invention provides peptides that selectively bind to mammalian atherosclerotic lesions. The present invention also provides methods for in vivo identification of peptides capable of binding to biomolecules as well as methods for identifying the targets of such binding moieties. Methods to diagnose or treat pathologic conditions that involve atherosclerotic lesions are also provided by the invention that involve administering to a mammal a peptide attached to a reporter molecule or a therapeutic agent, respectively.
    Type: Application
    Filed: August 9, 2002
    Publication date: November 15, 2007
    Applicant: The Scripps Research Institute
    Inventors: Cheng Liu, Thomas Edgington, Margaret Prescott
  • Targeted delivery to legumain-expressing cells
    Publication number: 20060135410
    Abstract: The present invention relates to new agents and methods useful for preventing, treating and diagnosing diseases such as cancer. For example, the invention relates to prodrug agents useful for targeting and delivering cytotoxic drugs to cancerous cells.
    Type: Application
    Filed: November 29, 2005
    Publication date: June 22, 2006
    Inventors: Cheng Liu, Thomas Edgington